<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Spark Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Spark Therapeutics, Inc.

    Spark Therapeutics, a fully integrated company, strives to challenge the inevitability of genetic disease by working to discover, develop and deliver gene therapies that address inherited retinal diseases (IRDs), neurodegenerative diseases, as well as diseases that can be addressed by targeting the liver. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $352,000,000
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Jeffrey D. Marrazzo
    • FOUNDED
      2013
    • EMPLOYEES
      251-500
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    IDEAYA Biosciences, Inc.

    IDEAYA Biosciences, Inc.

    IDEAYA is an oncology-focused precision medicine company committed to the discover...

    IDEAYA is an oncology-focused precision medicin...

    Filing Type:    PU
    H & G Science, Inc.

    H & G Science, Inc.

    H&G Science aims to facilitate the safe and effective treatment of diseases. Our g...

    H&G Science aims to facilitate the safe and eff...

    Amount Raised:    $24,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    BioCryst Pharmaceuticals, Inc.

    BioCryst Pharmaceuticals, Inc.

    BioCryst Pharmaceuticals discovers novel, oral small-molecule medicines that treat...

    BioCryst Pharmaceuticals discovers novel, oral ...

    Filing Type:    PU
    Fennec Pharmaceuticals Inc.

    Fennec Pharmaceuticals Inc.

    Fennec Pharmaceuticals, Inc., (NASDAQ: FENC; TSX: FRX) is a specialty pharmaceutic...

    Fennec Pharmaceuticals, Inc., (NASDAQ: FENC; TS...

    Filing Type:    PU
    Celgene Corporation

    Celgene Corporation

    Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global ...

    Celgene Corporation, headquartered in Summit, N...

    Filing Type:    PU
    Dova Pharmaceuticals, Inc.

    Dova Pharmaceuticals, Inc.

    Dova is a pharmaceutical company focused on acquiring, developing and commercializ...

    Dova is a pharmaceutical company focused on acq...

    Filing Type:    PU
    Benitec Biopharma Limited

    Benitec Biopharma Limited

    Benitec is a biotechnology company developing a proprietary therapeutic technology...

    Benitec is a biotechnology company developing a...

    Filing Type:    PU
    Fortress Biotech, Inc.

    Fortress Biotech, Inc.

    Fortress Biotech ("Fortress" or "the Company") is an innovative biopharmaceutical ...

    Fortress Biotech ("Fortress" or "the Company") ...

    Filing Type:    PU
    Audentes Therapeutics, Inc.

    Audentes Therapeutics, Inc.

    Audentes Therapeutics is a leading AAV-based genetic medicines company focused on ...

    Audentes Therapeutics is a leading AAV-based ge...

    Filing Type:    PU
    NeuBase Therapeutics, Inc.

    NeuBase Therapeutics, Inc.

    NeuBase Therapeutics, Inc. is developing its modular peptide-nucleic acid antisens...

    NeuBase Therapeutics, Inc. is developing its mo...

    Filing Type:    PU
    Magenta Therapeutics, Inc.

    Magenta Therapeutics, Inc.

    Magenta Therapeutics is a clinical-stage biotechnology company developing therapeu...

    Magenta Therapeutics is a clinical-stage biotec...

    Filing Type:    PU
    Stoke Therapeutics, Inc.

    Stoke Therapeutics, Inc.

    Stoke is pioneering a new way to treat the underlying cause of severe genetic dise...

    Stoke is pioneering a new way to treat the unde...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.